Varlilumab: A Deep Dive into CDX-1127 and its Mechanism Varlilumab (formerly known as PRT-052) represents a novel therapeutic agent targeting the CD27 receptor. The drug's mode of action involves engagement to this https://socialmediainuk.com/story27018033/text